Guru Ownership Trend
Guru Analysis for Atrium Therapeutics, Inc. (RNA)
Atrium Therapeutics, Inc. (RNA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $498,646.64.
Top institutional holders include Steven Cohen and Jeremy Grantham.
Institutional sentiment is currently Bearish. This is evidenced by a $119.61 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Jeremy Grantham reduced exposure by 90.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Atrium Therapeutics, Inc. (RNA)
Major holders include Steven Cohen ($303,606), Jeremy Grantham ($206,486). According to the latest reported data, 2 tracked investment managers collectively hold approximately 38,152 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $119.61 M, with 1 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 5 fully exited RNA. The total reported sell value was $119.92 M.
Yes, 1 managers opened new positions in RNA, and 0 increased their existing holdings. The total reported buy value was $303,606.